Pharmagreen Biotech (Pharmagreen Biotech) Scaled Net Operating Assets : -10.77 (As of Jun. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Pharmagreen Biotech Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Pharmagreen Biotech's operating assets for the quarter that ended in Jun. 2023 was $0.14 Mil. Pharmagreen Biotech's operating liabilities for the quarter that ended in Jun. 2023 was $1.89 Mil. Pharmagreen Biotech's Total Assets for the quarter that ended in Mar. 2023 was $0.16 Mil. Therefore, Pharmagreen Biotech's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2023 was -10.77.

Pharmagreen Biotech Scaled Net Operating Assets Historical Data

The historical data trend for Pharmagreen Biotech's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmagreen Biotech Scaled Net Operating Assets Chart

Pharmagreen Biotech Annual Data

Trend

Apr08

Apr09

Sep18

Sep19

Sep20

Sep21

Sep22

Scaled Net Operating Assets

Get a 7-Day Free Trial

-1.83

-3.54

-5.44

-4.00

Pharmagreen Biotech Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Scaled Net Operating Assets	Get a 7-Day Free Trial															-7.95	-7.82	-6.82	-7.55	-10.77

Competitive Comparison of Pharmagreen Biotech's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmagreen Biotech's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Pharmagreen Biotech's Scaled Net Operating Assets falls into.

Pharmagreen Biotech Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Pharmagreen Biotech's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Sep. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Sep. 2022 )
=	(Operating Assets (A: Sep. 2022 )	-	Operating Liabilities (A: Sep. 2022 ))	/	Total Assets (A: Sep. 2021 )
=	(0.201	-	1.694)	/	0.373
=	-4.00

where

	Operating Assets		(A: Sep. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.209	-	0.008
=	0.201

	Operating Liabilities		(A: Sep. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2.032	-	0.119	-	0.219
=	1.694

Pharmagreen Biotech's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2023 )
=	(Operating Assets (Q: Jun. 2023 )	-	Operating Liabilities (Q: Jun. 2023 ))	/	Total Assets (Q: Mar. 2023 )
=	(0.135	-	1.891)	/	0.163
=	-10.77

where

	Operating Assets		(Q: Jun. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.14	-	0.005
=	0.135

	Operating Liabilities		(Q: Jun. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2.291	-	0.12	-	0.28
=	1.891

Pharmagreen Biotech Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Pharmagreen Biotech's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmagreen Biotech (Pharmagreen Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmagreen Biotech Inc (OTCPK:PHBI) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

112 North Curry Street, Carson, NV, USA, 89703

Website

https://www.pharmagreen.ca

Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.